Literature DB >> 9573345

In-frame elimination of exon 10 in Cftrtm1Unc CF mice.

Z Xu1, V Gupta, D Lei, A Holmes, E Carlson, D C Gruenert.   

Abstract

Cystic fibrosis (CF) is a severe autosomal-linked inherited disease in humans. Transgenic CF animals play a crucial role in the study of molecular mechanisms underlying disease pathology. In the present study, CFTR mRNA expression was examined in different tissues from one CF mouse model that contains a disruption in exon 10 sequence of the CF transmembrane conductance regulator (CFTR) gene. Multiple tissue samples were collected from new-born normal (+/+), homozygous (-/-), and heterozygous (+/-) mice and compared for their CFTR mRNA expression. Total RNA samples were prepared from eight different tissues (nasal mucosa, trachea, lung, colon, intestine, pancreas, liver, gonads, and brain) and then analyzed by reverse transcription polymerase chain reaction (RT-PCR) amplification. A 329-bp fragment comprising exon 9 through exon 11 of the CFTR gene was amplified from all tissues of the normal mouse. In contrast, a 137-bp fragment was observed in tissue samples from homozygous CF mice. Both the 329-bp and 137-bp fragments were detected in samples from heterozygous mice. Direct sequencing analysis of the amplified fragments showed an exon 9-exon 11 splice junction, indicating that the entire exon 10 sequence was eliminated from homozygous CF mice. RT-PCR analysis of the 3' end of CFTR mRNA showed the presence of a 682-bp, exon 20-24 fragment in -/- and +/- mice. These results demonstrate that an alternately spliced CFTR mRNA is produced in this CF 'knock-out' mouse. A semi-quantitative comparison of the wild-type and exon 10 minus CFTR (CFTR-E10) mRNA in heterozygote animals indicated that less (but a detectable amount) mutant CFTR mRNA was present in all organs tested. There was, however, a significant reduction of CFTR-E10 mRNA in the liver and the pancreas. Since the deletion of exon 10 is in-frame, the significance of the CFTR-E10 mRNA in terms of CFTR protein and function requires further analysis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573345     DOI: 10.1016/s0378-1119(98)00090-0

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  5 in total

1.  CFTR is a tumor suppressor gene in murine and human intestinal cancer.

Authors:  B L N Than; J F Linnekamp; T K Starr; D A Largaespada; A Rod; Y Zhang; V Bruner; J Abrahante; A Schumann; T Luczak; A Niemczyk; M G O'Sullivan; J P Medema; R J A Fijneman; G A Meijer; E Van den Broek; C A Hodges; P M Scott; L Vermeulen; R T Cormier
Journal:  Oncogene       Date:  2016-01-11       Impact factor: 9.867

2.  Congenital tracheal malformation in cystic fibrosis transmembrane conductance regulator-deficient mice.

Authors:  Elise Bonvin; Philippe Le Rouzic; Jean-François Bernaudin; Charles-Henry Cottart; Clarisse Vandebrouck; Antoine Crié; Teresinha Leal; Annick Clement; Monique Bonora
Journal:  J Physiol       Date:  2008-05-01       Impact factor: 5.182

3.  Cystic fibrosis transmembrane conductance regulator is vital to sperm fertilizing capacity and male fertility.

Authors:  Wen Ming Xu; Qi Xian Shi; Wen Ying Chen; Chen Xi Zhou; Ya Ni; Dewi Kenneth Rowlands; Guo Yi Liu; Hu Zhu; Ze Gang Ma; Xiao Fei Wang; Zhang Hui Chen; Si Chang Zhou; Hong Shan Dong; Xiao Hu Zhang; Yiu Wa Chung; Yu Ying Yuan; Wan Xi Yang; Hsiao Chang Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-22       Impact factor: 11.205

4.  Expression and function of Anoctamin 1/TMEM16A calcium-activated chloride channels in airways of in vivo mouse models for cystic fibrosis research.

Authors:  Anne Hahn; Johanna J Salomon; Dominik Leitz; Dennis Feigenbutz; Lisa Korsch; Ina Lisewski; Katrin Schrimpf; Pamela Millar-Büchner; Marcus A Mall; Stephan Frings; Frank Möhrlen
Journal:  Pflugers Arch       Date:  2018-06-02       Impact factor: 3.657

5.  Influence of the cystic fibrosis transmembrane conductance regulator on expression of lipid metabolism-related genes in dendritic cells.

Authors:  Yaqin Xu; Christine Tertilt; Anja Krause; Luis E N Quadri; Ronald G Crystal; Stefan Worgall
Journal:  Respir Res       Date:  2009-04-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.